Northwest & Ethical Investments’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.09M	Sell	81,182 -3,970	-5%	-$318K	0.12%	164
2025 Q4	$8.13M	Buy	85,152 +5,021	+6%	+$492K	0.18%	133
2025 Q3	$7.81M	Buy	80,131 +7,581	+10%	+$785K	0.18%	140
2025 Q2	$7.78M	Sell	72,550 -1,800	-2%	-$182K	0.19%	141
2025 Q1	$7.5M	Sell	74,350 -78	-0.1%	-$7.85K	0.2%	142
2024 Q4	$6.65M	Buy	74,428 +330	+0.4%	+$29.1K	0.18%	162
2024 Q3	$6.21M	Buy	74,098 +35,336	+91%	+$2.79M	0.16%	163
2024 Q2	$2.99M	Buy	38,762 +33,366	+618%	+$2.44M	0.09%	212
2024 Q1	$370K	Buy	+5,396	New	+$347K	0.01%	358
2017 Q3	–	Sell	-5,138	Closed	-$142K	–	353
2017 Q2	$142K	Buy	5,138 +900	+21%	+$23.9K	0.01%	331
2017 Q1	$105K	Sell	4,238 -1,600	-27%	-$38.9K	0.01%	348
2016 Q4	$126K	Buy	+5,838	New	+$127K	0.01%	342